Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis

Abstract EN

Considering controversial data about the relationship between body size and prognosis of differentiated thyroid cancer (DTC), the current study aimed to assess the influence of body weight, body mass index (BMI), and body surface area (BSA) on DTC.

We conducted a retrospective analysis of patients’ records from the Thyroid Cancer Unit, assessing body size measures, clinical and laboratory prognostic factors, and disease evolution.

337 patients, aged 45.95 ± 13.04 years old, with BMI of 27.87 ± 5.13 kg/m2 and BSA of 1.74 ± 0.18 m2 were enrolled.

After 9.5 ± 6.9 years of follow-up, 87.29% of patients were disease-free and 12.71% had persistent disease; no patient had deceased.

Patients aged <45 years old with extrathyroidal invasion tumor had greater baseline body weight and BSA than those without extrathyroidal invasion (median 79.5 kg versus 67 kg and 1.85 m2 versus 1.74 m2).

Women with poorly differentiated tumor and patients aged ≥45 years old with distant metastasis presented greater weight loss during follow-up compared to patients without such characteristics (median −2 kg versus +1.5 kg and −3 kg versus +1 kg, respectively).

The relationship between body size and DTC evolution was not observed.

In conclusion, higher weight and BSA were associated with a greater chance of extrathyroidal tumor invasion in younger patients.

Specific subgroups of patients with aggressive disease presented higher weight loss.

Young patients with higher BSA should be carefully treated due to possible worse prognosis related to increased incidence of extrathyroid invasion.

Findings related to tumor aggressiveness and weight loss in specific groups deserve further mechanistic studies.